baber/WOPTO huggingface dataset:
Patent JP-H025764-B2 (JP)
IPC: C08F20/44
Filed: 1980-10-01
Abstract: An acrylonitrile polymer having an intrinsic viscosity in the range of 0.5 to 1.4 and a sulfonic acid end group content of about 0.20 to 0.35 weight percent is obtained by polymerizing acrylonitrile and one or more monomers free of acid dyesite groups in the presence of a redox system containing an oxidizing agent, a reducing agent, and a copper activator, the reducing agent being a mixture of a bisulfite and a mercapto compound in proportions which give the desired end group content whereby intrinsic viscosity can be varied independently.
Patent JP-3307646-B2 (JP)
IPC: A61N7/02
Filed: 1994-07-26
Granted: 2002-07-24
Abstract: The therapy and imaging probe of the invention comprises a probe body (20') of an elongate shape defining a general axis (X-X), one imaging transducer (40') for transmitting imaging waves, and one therapy transducer (30') for transmitting therapy waves. The imaging transducer is mounted on first support means providing translational movement of the imaging transducer within the probe, parallel to the general axis (X-X) of the probe, between a withdrawn position and an extended position. The therapy transducer is mounted on second support means providing rotation of the therapy transducer within the probe, about an axis of rotation (X1-X1) parallel to the general axis (X-X) of the probe but offset with respect to the imaging transducer, to allow rotation of the therapy transducer between a withdrawn position and a treatment position. In the withdrawn or non-active position of the therapy transducer, the imaging transducer may be brought by translational movement to its extended position to occupy the place occupied by the therapy transducer in its treatment position. Thus, the imaging transducer may form an image of a region for treatment by the therapy transducer. In the treatment position of the therapy transducer, the imaging transducer is at its withdrawn position. The therapy transducer, during the transmission of therapy waves, directly transmits the therapy waves in a direction substantially identical to the direction in which the imaging transducer transmits the imaging waves when imaging waves are being transmitted.
Patent JP-3049091-B2 (JP)
IPC: A61K48/00
Filed: 1991-03-20
Granted: 2000-06-05
Abstract: The present invention relates to a method for regulating neuron development/maintenance and/or regeneration in a nervous system of a mammal and to pharmaceutical compositions comprising leukaemia inhibitory factor useful for same.
Patent JP-H0617449-B2 (JP)
IPC: C08G59/32
Filed: 1987-09-10
Abstract: Halogenated aromatic epoxy resins are disclosed wherein the halogen atoms are in the meta position with respect to a glycidyl ether group attached to an aromatic ring. Advanced epoxy resins are disclosed which result from the reaction of a relatively low molecular weight epoxy resin and a polyhydric phenol wherein at least one of the reactants contains at least one halogen atom which is meta with respect to a glycidyl ether group or a hydroxyl group attached to an aromatic ring. These advanced epoxy resins, when cured with a suitable curing agent, possess an improvement as compared to an advanced epoxy resin containing halogen atoms which are ortho with respect to a glycidyl ether group in at least one of thermal stability, glass transition temperature, relationship of viscosity to molecular weight and resistance to forming hydrolyzed halides in the presence of a refluxing solution of an alkali metal hydroxide.
Patent JP-3023801-B2 (JP)
IPC: B61L7/10
Filed: 1990-04-06
Granted: 2000-03-21
Abstract: PCT No. PCT/FR90/00245 Sec. 371 Date Nov. 30, 1990 Sec. 102(e) Date Nov. 30, 1990 PCT Filed Apr. 6, 1990 PCT Pub. No. WO90/12411 PCT Pub. Date Oct. 18, 1990.An apparatus for monitoring at a distance the open or closed state of at least one contact. The installation consists of a non-security control circuit made up of coder couples (such as CM1, CV1 CM2, CV2 and CM3 CV3) and a microcontroller (1), connected by a modem (2) and a data transmission link (3) to a central security control (LST). This installation is useful in the railway domain, to remotely monitor contacts.
Patent JP-3875726-B2 (JP)
IPC: H03H11/12
Filed: 1997-06-17
Granted: 2007-01-31
Abstract: An electronic circuit comprises coupled transconductors (TR1 and TR2). The transconductors comprise two complementary differential pairs whose outputs are connected directly to two output terminals. Two diodes (P3, N3) are arranged in series between the common terminals of the differential pairs. The common-mode voltage of the differential pairs is available on the node between the two diodes. The common-mode voltage of the one transconductor (TR2) is used to control one of the bias current sources of the other transconductor (TR1) and, if desired, also that of the one transconductor (TR2). In this way the common-mode voltage on the output terminals of the other transconductor (TR1) is fixed.
Patent JP-3265577-B2 (JP)
IPC: C12Q1/68
Filed: 1993-09-30
Granted: 2002-03-11
Abstract: Methods of diagnosing or prognosing Alzheimer's disease in a subject are disclosed. The methods involve directly or indirectly detecting the presence or absence of an apolipoprotein E type 4 (ApoE4) isoform or DNA encoding ApoE4 in the subject. The presence of ApoE4 indicates the subject is afflicted with Alzheimer's disease or at risk of developing Alzheimer's disease. A novel immunochemical assay for detecting the presence or absence of the Apoliprotein E (ApoE) E4 allele in a subject is also disclosed.
Patent JP-2664804-B2 (JP)
Inventor: CAPUT DANIEL
IPC: C12N15/70
Filed: 1990-07-13
Granted: 1997-10-22
Abstract: The invention concerns a new urate oxidase activity protein which has the sequence (I), possibly preceeded by a methionine, or in that it may present a degree of substantial homology with this sequence. The invention is also aimed at medicines containing this protein, as well as the genetic engineering implements to obtain it.
Patent JP-3032297-B2 (JP)
IPC: C07D295/12
Filed: 1994-10-17
Granted: 2000-04-10
Abstract: PCT No. PCT/US94/12135 Sec. 371 Date May 2, 1996 Sec. 102(e) Date May 2, 1996 PCT Filed Oct. 17, 1994 PCT Pub. No. WO95/10295 PCT Pub. Date Apr. 20, 1995The present invention relates to azacycloalkylalkanoyl peptides and pseudopeptides which inhibit platelet aggregation and thrombus formation thereby being useful in the prevention and treatment of thrombosis associated with disease states such as myocardial infarction, stroke, peripheral arterial disease, and disseminated intravascular coagulation, to methods for the prevention or treatment of thrombosis in a mammal in need of such therapy comprising the administration of a therapeutically effective amount of such compounds, and to pharmaceutical compositions comprising such compounds.
Patent JP-4143126-B2 (JP)
IPC: A61K31/135
Filed: 1997-09-15
Granted: 2008-09-03
Abstract: A compound of formula Ior a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering lipid levels and/or increasing the HDL: LDL cholesterol ratio in humans, for example in humans having hyperlipidaemia, hypercholesterolaemia or hypertriglyceridaemia.
Patent JP-3369176-B2 (JP)
IPC: H04B7/005
Filed: 1993-04-08
Granted: 2003-01-20
Abstract: Measurements of mobile signal strength received at the base station are used to determine the portion of power that should be transmitted by the base station to a particular mobile. Each of a plurality of mobiles measure the relative strength of the base station signal specifically intended for that mobile. The relative strength is compared to either the total base station signal power or to a cumulative ranking of the power of signals intended for other mobiles. That comparison is used to determine whether the mobile should increase or decrease its power.
Patent JP-4027418-B2 (JP)
IPC: G01R27/06
Filed: 1995-12-12
Granted: 2007-12-26
Abstract: A handheld vector network analyzer (VNA) providing a wide bandwidth test signal FO utilizing a narrowband test signal synthesizer which provides the test signal through a frequency divider or harmonic generator. With a 550-1100 MHz narrowband test signal synthesizer, a test signal FO can range from 25 MHz to 3.3 GHz. To make a tracking synthesizer operate more independent of the test signal synthesizer, a LO signal is produced using the tracking synthesizer with its phase detector input connected through a frequency divider to the output of the test signal synthesizer. Synchronous detectors are further included which provide incident and reflected IF signals to take advantage of the maximum range of an A/D converter. To better enable operation in the presence of external signals, feedback is provided from the synchronous detectors to sweep the frequency of a reference oscillator.
Patent JP-3618747-B2 (JP)
IPC: B65D55/02
Filed: 1994-03-11
Granted: 2005-02-09
Abstract: PCT No. PCT/SE94/00201 Sec. 371 Date Dec. 21, 1995 Sec. 102(e) Date Dec. 21, 1995 PCT Filed Mar. 11, 1994 PCT Pub. No. WO94/20712 PCT Pub. Date Sep. 15, 1994The invention relates to an anti-shop lifting device, intended to be passed onto and locked to a bottle-neck having an external circumferential bead. The device comprises an outer socket (15) which can be shifted in relation to an inner socket (10) between two end positions and is locked by latch means (24) in one end position. A number of retainers (21) distributed peripherally on the inner surface of the outer socket, when the outer socket is in said one end position extend into the inner socket through openings (13) in the wall of said inner socket to an engaged position in which the retainers engage behind the bead of the bottle-neck in order to prevent the anti-shop-lifting device form being withdrawn. The latch means (24) is biased to latching position but can be actuated by means of an external element (13) to a disengaged position against the bias in order to allow movement of the retainers from the engaged position and thus withdrawal of the anti-shop-lifting device from the bottle-neck.
Patent JP-4510147-B2 (JP)
IPC: A61K38/08
Filed: 1996-03-28
Granted: 2010-07-21
Abstract: Compounds and compositions for eliciting or enhancing immune reactivity to HER-2/neu protein are disclosed. The compounds include polypeptides and nucleic acid molecules encoding such peptides. The compounds may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
Patent JP-3138481-B2 (JP)
IPC: A61K35/14
Filed: 1997-02-26
Granted: 2001-02-26
Abstract: The use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition for treating an auto-immune disease, particularly an auto-immune disease induced by a defect in CD4+ T cell immunoregulation, is disclosed.
Patent JP-3249134-B2 (JP)
IPC: C12N5/08
Filed: 1996-05-22
Granted: 2002-01-21
Abstract: A Namalwa cell line which is free of squirrel monkey retrovirus is useful for alpha-interferon production. The cell line can be used for the expression of recombinant polypeptides. It can be emplyed for packaging viruses for use in gene therapy.
Patent JP-3181299-B2 (JP)
IPC: A61B19/00
Filed: 1998-04-30
Granted: 2001-07-03
Abstract: A device for retracting edges of an incision in a surface to form an opening including: a flexible, tubular skirt having an upper end, a lower end, and a channel therebetween; a ring connected to the lower end of the skirt for maintaining the lower end in an open configuration and defining an exit opening to the channel; and an inflatable collar connected to the skirt and surrounding the upper end. The ring is designed to fit through the incision and remain under the surface when it is oriented parallel to the surface. The collar, when inflated, maintains the upper end in an open configuration and defines an entry opening to the channel. During use, the ring is inserted through the incision and the collar is inflated while remaining outside of the incision, thereby drawing the skirt against the edges of the incision and retracting the edges of the incision to form the opening. The retracting device can be included in a surgical access port, which further includes a flexible sleeve connected to at least one of the inflatable collar and the skirt, extending the channel from the exit opening of the skirt to an open end of the flexible sleeve distal to the skirt. The device can include a light source in the vicinity of the exit opening.
Patent ES-2165301-B2 (ES)
Title: Perfeccionamientos en contenedores ligeros y contenedores asi perfeccionados.
Inventor: MUR GIMENO EMILIO
IPC: B65D5/00
Filed: 2000-02-02
Granted: 2003-11-01
Abstract: Perfeccionamientos en contenedores ligeros y contenedores así perfeccionados. Comprende esta invención, unos perfeccionamientos introducidos en contenedores ligeros, construidos generalmente, en cartón ondulado, mediante cuyos perfeccionamientos se obtiene un contenedor perfeccionado sobre el que es posible superponer y anclar otro contenedor igual o semejante o bien dos contenedores de menores proporciones, quedando eficazmente apoyados y retenidos sobre el contenedor de base. Mediante los perfeccionamientos que propone la invención, se forma entre cada dos contenedores superpuestos, seis espacios libres, por los que circulará el aire necesario para la buena conservación de los productos envasados. Asimismo, los contenedores perfeccionados que se proponen, han sido dotados de amplios sectores de anclaje y apoyo para permitir superponer, con seguridad, otros contenedores para formar apilamientos, obteniendo con todo ello, beneficios y efectos nuevos, tanto del orden económico como práctico.
Patent ES-2183703-B2 (ES)
Title: Metodo para la obtencion en un mismo patron del delantero y la espalda de un vestido u otra prenda similar.
Inventor: JIMENEZ MENDOZA ISABEL
IPC: A41H3/00
Filed: 2001-02-06
Granted: 2003-12-16
Abstract: Método para la obtención en un mismo patrón del delantero y la espalda de un vestido u otra prenda similar. Este método contempla en una primera fase la obtención del patrón correspondiente al delantero de un vestido y en una segunda fase la obtención del patrón correspondiente a la espalda del vestido, encontrándose éste relacionado con el anterior por la prolongación de las líneas correspondientes al pecho, la cintura, la cadera y el bajo del patrón delantero. La obtención de dichos patrones se lleva a cabo mediante el trazado de una serie de líneas y puntos que determinan los contornos de los patrones correspondientes al delantero y a la espalda, asegurando su correspondencia.
Patent ES-2219153-B2 (ES)
Inventor: BANULS FEMENIA VICENTE
IPC: H02G3/04
Filed: 2002-07-31
Granted: 2005-07-16
Abstract: Grid tray for electrical conductors. <??>This consists of the tray itself, consisting of longitudinal rows of rods, welded to transversal rows of rods to form rectangles. A feature claimed is a bend before and after each weld on the longitudinal rods, which raises the longitudinal rod to the level of the transversal rod, so that the whole assembly is on a plane of similar height. <??>The method for forming this grid is also claimed, consisting in electro-welding, transversal bending of each section of longitudinal rod, either simultaneously to this or at a later time, and longitudinal bending of the edges. <??>For application in making grid trays for electrical conductors. <IMAGE>
Patent IE-S86601-B2 (IE)
Title: An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level
Inventor: CLUBE JASPER
IPC: A61K39/00
Filed: 2014-11-07
Abstract: An injectable preparation comprising an antibody or antibody fragment, for use in reducing cholesterol level or maintaining previously reduced cholesterol level in a human in need thereof. The antibody or fragment of the preparation comprises a VH domain derived from the recombination of a human VH gene segment, a human D gene segment and a human JH gene segment. The human VH segment encodes the framework 1 of SEQ ID NO: 40. The antibody or fragment specifically binds a proprotein convertase subtilisin/kexin type 9 (PCSK9) amino acid sequence that comprises a C-terminal domain comprising a mutation E670G in SEQ ID NO:1. The human comprises a nucleotide sequence encoding a PCSK9 comprising a mutation E670G in SEQ ID NO: 1. The human also comprises a VH gene segment encoding the framework 1 of SEQ ID NO: 40.
Patent AU-2001241742-B2 (AU)
Title: 103p2d6: tissue specific protein highly expressed in various cancers
Inventor: MITCHELL STEVE CHAPPELL
IPC: C12Q1/68
Filed: 2001-02-26
Granted: 2006-04-06
Abstract: A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2SD6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
Patent AU-2002218447-B2 (AU)
Title: Fad4, Fad5, Fad5-2, and Fad6, fatty acid desaturase family members and uses thereof
Inventor: QIU XIAO
IPC: A23L33/00
Filed: 2001-09-28
Granted: 2007-03-29
Abstract: The invention provides isolated nucleic acid molecules which encode novel fatty acid desaturase family members. The invention also provides recombinant expression vectors containing desaturase nucleic acid molecules, host cells into which the expression vectors have been introduced, and methods for large-scale production of long chain polyunsaturated fatty acids (LCPUFAs), e.g., DHA.
Patent AU-2002221528-B2 (AU)
Title: Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
Inventor: MULLER PETER-JURGEN
IPC: A61K31/728
Filed: 2001-10-19
Granted: 2007-03-22
Abstract: Rheumatoid arthritis is a chronic inflammatory disease, leading to joint destruction. Conventional therapy is based on pain-reduction and an improvement in the frictional properties of joints, in order to delay the time for operative intervention. A lack of specifically-acting agents for drug-based therapy for arthritis exists. The formulations comprise sulphated hyaluronic acids with varying degrees of sulphation, or the pharmacologically acceptable salts thereof and, optionally, hyaluronic acid and/or hyaluronic acid uronide. The pharmaceutical formulations are highly concentrated injection preparations with an aqueous, viscous, gel-like, or paste-like form, or a low-concentration rinsing fluid for intra-articular application.
Patent AU-2002254672-B2 (AU)
Title: Ink container configured to establish reliable fluidic connection to a receiving station
Inventor: TAYLOR JOHN L
IPC: B41J2/175
Filed: 2002-04-17
Granted: 2006-08-17
Abstract: The present disclosure relates to a replaceable ink container for providing ink to an inkjet printing system. The inkjet printing system is of the type having a receiving station for receiving the replaceable ink container. The receiving station has a fluid inlet and a sealing structure. The replaceable ink container includes a reservoir defining a fluid outlet and a sealing surface proximate the fluid outlet. The replaceable ink container also includes a sealing material contained within the reservoir for wetting the sealing surface to seal defects between the sealing surface and the sealing structure.
Patent AU-2002259066-B2 (AU)
Title: Model-based alarming
Inventor: SINGH ABTAR
IPC: G06Q10/08
Filed: 2002-04-29
Granted: 2007-05-31
Abstract: A method includes calculating an energy consumption model for at least one component of a building system, accessing actual weather data, applying the actual weather data to the energy consumption model, and determining an expected energy consumption value for the at least one component of the building system based on the applying.
Patent AU-2002317050-B2 (AU)
Title: Vehicle suspension stabilising arrangement
Inventor: CONTARINO ALDO
IPC: B62K5/00
Filed: 2002-07-26
Granted: 2008-10-02
Abstract: A stabilizing arrangement (100) characterized by a mounting member (32), at least one forward truck (34) supporting a forward pair of surface engaging members (36), and at least one rear truck (38) supporting a rear pair of surface engaging members (40), each truck (34, 38) allowing biased rotation about a central axis thereof, the forward truck (34) being mounted on the mounting member (32) such that it projects forwardly thereof and the rear truck (38) being mounted on the mounting member (32) such that it projects rearwardly thereof, and whereby the mounting member (32) is supported substantially between the trucks (34, 38) and pairs of surface engaging members (36, 40). A suspension and steering arrangement is also provided.
Patent AU-2002333726-B2 (AU)
Title: Initialization of a chip card
Inventor: VATER HARALD
IPC: G07F7/10
Filed: 2002-08-27
Granted: 2008-07-17
Abstract: In a method for reading initialization data (IND) into a chip card, the chip card receives an encrypted authentication value (EAV) and decrypts it to obtain at least one release key (ENK). The release key (ENK) is checked for a match with a release key (ENK′) stored on the chip card (14). If there is a match, the initialization data (EIND, IND) are received and written to a nonvolatile memory of the chip card. A method for generating a record for initializing a chip card. a chip card and a computer-readable data carrier have corresponding features. The invention is provided in particular for initialization of chip cards by external partners of the chip card manufacturer, whereby as few possibilities of attack as possible are to be offered.
Patent AU-2003213311-B2 (AU)
Title: Danger detection system
Inventor: KAESTLI URS
IPC: G08B25/10
Filed: 2003-07-08
Granted: 2007-08-09
Abstract: Alarm system has a central unit (1) with a multiplicity of connected alarms (2-5) and an operating unit (6) for operation or testing of the alarms. The alarms and operating unit are linked via a two-way communication system and the alarms also act as connection nodes to link the operating unit to the central unit.
Patent AU-2004216486-B2 (AU)
Title: Activation and production of radiolabeled particles
Inventor: APOSTOLIDIS CHRISTOS
IPC: G21G1/12
Filed: 2004-02-27
Granted: 2009-08-06
Abstract: A method for activating particles for internal radiopharmaceutical use, said particles comprising precursor nuclides to be activated, is disclosed. The method comprises: 
directing a high-intensity laser beam (10) onto converting means (12) to produce an irradiating field of protons; and 
irradiating said particles comprising precursor nuclides (18) in said irradiating field of protons to activate said precursor nuclides, thereby obtaining radiolabeled particles.
Patent AU-2004220616-B2 (AU)
Title: Kink resistant endovascular graft
Inventor: CHOBOTOV MICHAEL V
IPC: A61F2/06
Filed: 2004-03-05
Granted: 2010-01-21
Abstract: An intracorporeal device, such as an endovascular graft (96), having a tubular section (97) with circumferential or helical radial support members (98). The radial support members may be inflatable channels which support the tubular structure of the graft and which are appropriately sized and longitudinally spaced to prevent or reduce kinking of the tubular structure upon bending of the tubular structure. The circumferential inflatable channels are disposed in three different longitudinal sections (99,104,108) wherein the longitudinal spacing of the circumferential inflatable channels in each longitudinal section has a predetermined value that may be chosen to match a bend radius of a patient's intracorporeal conduit.